MAXYFILL® Body Contouring Filler (1 x 70 mL / 70cc) | Quiver Medic (South Korea)
Short Description
An ultra-high-capacity, macro-volumizing Hyaluronic Acid body filler formulated with 20–24 mg/mL of cross-linked HA utilizing proprietary HENM (High Entangled Net Matrix) technology. Supplied in an economical 70 mL (70cc) sterile vial, MAXYFILL® is engineered specifically for deep subcutaneous and supra-fascial placement to deliver strong mechanical lift ($G’$), cohesive structural projection, and long-lasting shape retention for non-surgical gluteal enhancement, hip dip correction, leg sculpting, and post-liposuction contour reconstruction lasting 12 to 15+ months (up to 24 months with maintenance).
Detailed Description
MAXYFILL® 70 mL is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable manufactured in South Korea by Quiver Medic. Developed specifically for large-scale non-surgical body contouring and soft-tissue reconstruction, it provides aesthetic surgeons and physicians with the physical volume and high viscoelastic lift required to reshape major anatomical zones without general anesthesia, surgical implants, or surgical autologous fat grafting.
Synthesized from pure, non-animal bio-fermented hyaluronic acid, MAXYFILL utilizes HENM Technology (High Entangled Net Matrix). This specialized multi-phase cross-linking process creates a dense, three-dimensionally interwoven hydrogel network with high elastic modulus ($G’$) and viscosity. When placed into deep subcutaneous compartments, the hydrogel withstands strong gravitational load, muscular shear, and mechanical compression from continuous body movement (such as the gluteus maximus, tensor fasciae latae, and quadriceps) without flattening, spreading laterally, or migrating into neighboring fascial layers.
Purified through exhaustive multi-stage dialysis washing, unreacted BDDE cross-linker monomers and bacterial endotoxins are reduced to negligible trace levels. The resulting hydrogel delivers high tissue biocompatibility, minimizing post-treatment swelling, erythema, and recovery downtime. With its 70 mL macro-capacity presentation, MAXYFILL provides high procedural efficiency and clinic economics for large-area body protocols.
Treatment Areas & Indications
-
Gluteal Augmentation & Buttock Reshaping:
-
Non-surgical buttock projection, upper-pole fullness, and roundness enhancement
-
Correction of lateral gluteal depression and age-related volume deflation
-
-
Lateral Pelvic Contouring & Hip Dip Correction:
-
Effacement and smooth blending of lateral pelvic hollows (trochanteric depressions / hip dips)
-
Harmonization of the waist-to-hip silhouette
-
-
Lower Extremity Contouring & Leg Symmetry:
-
Calf sculpting, medial/lateral volume enhancement, and lower-leg curvature correction
-
Asymmetry correction between the lower limbs
-
-
Post-Surgical Defect Correction & Soft-Tissue Alignment:
-
Smoothing of post-liposuction contour irregularities, divots, and cannula track depressions
-
Reconstruction of post-traumatic soft-tissue indentations and localized lipoatrophy
-
Key Clinical Advantages
-
Generous 70 mL (70cc) Macro-Capacity: Specifically packaged for large-scale body treatments, significantly reducing the cost-per-mL and eliminating the operational complexity of opening dozens of individual syringes.
-
Proprietary HENM Cross-Linking: Creates an entangled, cohesive hydrogel matrix that maintains defined projection against continuous body weight and muscular tension.
-
Strong Resistance to Lateral Migration: High cohesive density anchors the gel at the targeted injection plane, preventing horizontal dispersion into unintended fascial or adipose compartments.
-
Reversible & Biocompatible: Fully biocompatible non-animal HA that can be enzymatically dissolved with hyaluronidase if adjustment or reversal is required, offering an established safety margin over permanent polymer fillers.
-
Exhaustive Dialysis Purification: Rigorous washing cycles eliminate residual cross-linkers and bacterial byproducts, reducing post-treatment edema, tissue inflammation, and recovery downtime.
-
Smooth Blunt-Cannula Delivery: Extrudes evenly through 16G–18G body microcannulas, ensuring continuous extrusion force and uniform retrograde fanning across broad tissue planes.
-
Extended In Vivo Longevity: Dense cross-linking and large total mass provide high resistance to enzymatic hyaluronidase breakdown, sustaining aesthetic results for 12 to 15+ months (and up to 24 months with touch-up maintenance).
Technical Specifications
| Parameter | Specification |
| Active Substance | Cross-linked Sodium Hyaluronate (non-animal bio-fermentation) |
| HA Concentration | 20 – 24 mg/mL |
| Cross-Linking Technology | HENM Technology (High Entangled Net Matrix, BDDE-based) |
| Lidocaine Content | Lidocaine-Free (can be blended with local anesthetic/sterile saline per clinic protocol) |
| Packaging Presentation | 1 x 70 mL (70cc) sterile glass vial |
| Target Injection Plane | Deep subcutaneous adipose layer or supra-fascial plane |
| Recommended Injection Tools | 16G / 18G blunt-tip body microcannulas (100–150 mm length) |
| Recommended Injection Techniques | Retrograde linear fanning, criss-cross tunneling, and multi-planar subcutaneous deposition |
| Expected Clinical Duration | 12 to 15+ months (up to 24 months with maintenance sessions) |
| Storage Instructions | Store between 2°C to 25°C (36°F to 77°F); protect from direct sunlight and freezing |
| Manufacturer / Origin | Quiver Medic Co., Ltd. |
| (South Korea) | Regulatory Category | CE-marked Medical Device / Prescription Only (Rx) |
Professional Advisory: MAXYFILL® 70 mL is a high-volume body filler intended strictly for certified plastic surgeons, dermatologists, and credentialed aesthetic physicians trained in large-bore blunt-cannula body contouring, deep fascial anatomy, and vascular safety protocols. Injection into the breast parenchyma (glandular tissue), face, glabella, periorbital zone, or superficial intradermal layer is strictly contraindicated.






Reviews
There are no reviews yet.